Vanguard PRIMECAP Fund Investor Shares (VPMCX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.94: the stock has moved about 6% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerVanguard PRIMECAP Fund Investor Shares (VPMCX) trades at $225.63. Vanguard PRIMECAP Fund Investor Shares (VPMCX) is a large- and mid-cap growth fund managed by PRIMECAP Management Company. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for VPMCX: VPMCX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Vanguard PRIMECAP Fund Investor Shares (VPMCX) Financial Services Profile
Vanguard PRIMECAP Fund Investor Shares (VPMCX) is a large- and mid-cap growth fund distinguished by its long-term investment strategy, low portfolio turnover, and multi-manager approach, primarily focusing on the technology and healthcare sectors, offering diversification within a long-term investment portfolio.
What Is the Investment Thesis for VPMCX?
The fund's multi-manager approach diversifies investment ideas, potentially mitigating risk. The fund's low turnover rate reduces transaction costs and promotes tax efficiency. However, the fund's concentration in the technology and healthcare sectors could lead to volatility, especially during market downturns in these sectors. With a beta of 0.94, the fund exhibits slightly lower volatility than the overall market. The fund's success hinges on the continued growth of its key holdings and the ability of its multiple managers to identify and capitalize on emerging opportunities within the large- and mid-cap growth space. Investors may want to evaluate their risk tolerance and investment horizon when evaluating VPMCX.
Based on FMP financials and quantitative analysis
VPMCX Key Highlights
Market capitalization of $79.94 billion, indicating a substantial asset base.
- Beta of 0.94, suggesting slightly lower volatility compared to the broader market.
- Managed by PRIMECAP Management Company since its inception in 1984, demonstrating a long-standing track record.
- Employs a multi-manager approach, diversifying investment ideas and reducing reliance on single manager performance.
- Focuses on large- and mid-capitalization growth stocks, targeting companies with significant growth potential.
Who Are VPMCX's Competitors?
VPMCX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AMFCX American Funds American Mutual Fund | $62.88 | +0.83% | $75.7B | — |
| AMPFX American Funds AMCAP Fund | $45.53 | +0.60% | $94.7B | — |
| SGENX First Eagle Global Fund | $86.72 | +0.14% | $72.0B | — |
| VBINX Vanguard Balanced Index Fund | $54.53 | +0.41% | $63.5B | — |
| BLK BlackRock, Inc. | $1079.42 | +1.22% | $167B | 51 5-pillar |
| BX Blackstone Inc. | $113.36 | +1.54% | $137B | 66 5-pillar |
| APOS Apollo Global Management, Inc. | $25.60 | +0.04% | $74.9B | 56 5-pillar |
| BAM Brookfield Asset Management | $45.21 | +1.07% | $72.2B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are VPMCX's Key Strengths?
Long-term investment approach.
- Low portfolio turnover.
- Multi-manager structure.
- Established track record.
What Are VPMCX's Weaknesses?
Concentration in technology and healthcare sectors.
- Potential for short-term volatility.
- Lack of dividend income.
- Dependence on PRIMECAP Management Company.
What Are the Key Risks for VPMCX?
Market corrections in technology and healthcare sectors.
- Underperformance by one or more of the fund's managers.
- Increased competition from lower-cost passive funds.
- Concentration risk due to sector allocation.
What Threats Does VPMCX Face?
- Market downturns in technology and healthcare.
- Increased competition from passive investment strategies.
- Changes in investor sentiment.
- Regulatory changes.
What Are VPMCX's Competitive Advantages?
- Established track record since 1984 provides credibility and investor confidence.
- Multi-manager approach diversifies investment ideas and reduces key-person risk.
- Low turnover strategy minimizes transaction costs and enhances tax efficiency.
- Vanguard's brand reputation for low-cost investing attracts cost-conscious investors.
What Does VPMCX Do?
Vanguard PRIMECAP Fund Investor Shares (VPMCX) was established in 1984 and is managed by PRIMECAP Management Company. The fund focuses on large- and mid-capitalization growth stocks, employing a distinctive investment approach characterized by a long-term perspective and minimal portfolio turnover. PRIMECAP utilizes a multi-manager system, where several portfolio managers independently oversee portions of the fund. This structure aims to diversify investment ideas and reduce reliance on any single investment philosophy. The fund's investment strategy often leads to significant allocations in the technology and healthcare sectors, which can result in performance volatility if these sectors experience market fluctuations. With a market capitalization of $79.94 billion, VPMCX is designed to complement a diversified portfolio for investors with a long-term investment horizon. The fund does not distribute dividends, focusing instead on capital appreciation. Its core strategy emphasizes identifying companies with strong growth potential and holding them for extended periods, aligning with a buy-and-hold investment philosophy.
What Products and Services Does VPMCX Offer?
- Invests in a diversified portfolio of large- and mid-capitalization growth stocks.
- Employs a multi-manager approach with independent portfolio managers.
- Focuses on long-term capital appreciation rather than dividend income.
- Maintains a low portfolio turnover rate to minimize transaction costs.
- Concentrates investments in sectors such as technology and healthcare.
- Provides investors with exposure to a growth-oriented investment strategy.
- Offers a fund designed to complement a diversified portfolio with a long-term focus.
How Does VPMCX Make Money?
- Generates revenue through management fees charged as a percentage of assets under management (AUM).
- AUM growth is driven by investment performance and net investor inflows.
- Expenses include management fees paid to PRIMECAP Management Company and operational costs.
What Industry Does VPMCX Operate In?
Vanguard PRIMECAP Fund Investor Shares operates within the asset management industry, which is characterized by intense competition and evolving market dynamics. The fund competes with other growth-oriented mutual funds, including AMFCX, AMPFX, AMRFX, SGENX, and VBINX. The industry is influenced by macroeconomic factors, investor sentiment, and regulatory changes. Trends such as the increasing popularity of passive investing and the growing demand for sustainable investment options are reshaping the competitive landscape. VPMCX differentiates itself through its multi-manager approach and long-term investment philosophy, aiming to deliver consistent returns over extended periods.
Who Are VPMCX's Key Customers?
- Individual investors seeking long-term growth.
- Retirement savers looking for capital appreciation.
- Institutional investors seeking exposure to growth stocks.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 43 snapshots
| 2026-08-23 | 44 |
| 2026-08-31 | 44 |
| 2026-09-08 | 44 |
| 2026-09-16 | 44 |
| 2026-09-24 | 44 |
| 2026-10-04 | 44 |
| 2026-10-06 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved +1.2%.
VPMCX Financials
Bull Case vs Bear Case
Bull Case
- Long-term investment approach.
- Low portfolio turnover.
- Multi-manager structure.
- Established track record.
Bear Case
- Concentration in technology and healthcare sectors.
- Potential for short-term volatility.
- Lack of dividend income.
- Dependence on PRIMECAP Management Company.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
VPMCX Latest News
No recent news available for VPMCX.
VPMCX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for VPMCX.
Price Targets
Wall Street price target analysis for VPMCX.
VPMCX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for VPMCX; grades run from A+ (80-100) to F (below 30).
VPMCX Financials Stock FAQ
What do analysts say about VPMCX stock?
As a mutual fund, VPMCX does not have individual stock analyst ratings. However, performance is evaluated based on its returns relative to its benchmark and peer group.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The information provided is based on available data and should not be considered investment advice.
- Investors should conduct their own research and consult with a financial advisor before making investment decisions.